The peroxisome proliferator-activated receptor γ agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway.
about
Therapeutic Treatment of Arthritic Mice with 15-Deoxy Δ12,14-Prostaglandin J2 (15d-PGJ2) Ameliorates Disease through the Suppression of Th17 Cells and the Induction of CD4+CD25-FOXP3+ Cells.Functional role of PPAR-γ on the proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis
P2860
The peroxisome proliferator-activated receptor γ agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
The peroxisome proliferator-ac ...... dent osteoclastogenic pathway.
@en
The peroxisome proliferator-ac ...... dent osteoclastogenic pathway.
@nl
type
label
The peroxisome proliferator-ac ...... dent osteoclastogenic pathway.
@en
The peroxisome proliferator-ac ...... dent osteoclastogenic pathway.
@nl
prefLabel
The peroxisome proliferator-ac ...... dent osteoclastogenic pathway.
@en
The peroxisome proliferator-ac ...... dent osteoclastogenic pathway.
@nl
P2093
P2860
P356
P1476
The peroxisome proliferator-ac ...... dent osteoclastogenic pathway.
@en
P2093
Claire Bastien
Daniel Chappard
David Moulin
Georges Weryha
Jean-Yves Jouzeau
Meriem Koufany
Patrick Netter
P2860
P304
P356
10.1002/ART.38130
P577
2013-12-01T00:00:00Z